Moderna
MRNA
#1021
Rank
ยฃ14.92 B
Marketcap
ยฃ38.78
Share price
-2.95%
Change (1 day)
-35.29%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : ยฃ3.06 Billion

According to Moderna 's latest financial reports the company's total liabilities are ยฃ3.06 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Moderna - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ3.58 B-35.54%
2022-12-31ยฃ5.56 B-28.6%
2021-12-31ยฃ7.79 B122.51%
2020-12-31ยฃ3.50 B1008.18%
2019-12-31ยฃ0.31 B-7.08%
2018-12-31ยฃ0.34 B0.15%
2017-12-31ยฃ0.33 B-27.13%
2016-12-31ยฃ0.46 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ4.57 M-99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ53.19 B 1,638.46%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ33.79 M-98.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.21 B 5.16%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ46.33 B 1,414.19%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
ยฃ0.42 B-86.27%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ83.38 B 2,625.03%๐Ÿ‡บ๐Ÿ‡ธ USA